Naotoshi Sugimoto, Junji Tanaka, Masahiro Tsuda, Wataru Okamoto, Hiroyuki Okuda, Hiroshi Imamura, Toshio Shimokawa, Daisuke Sakai, Yukinori Kurokawa, Yoshito Komatsu, Chikashi Ishioka, Toshimasa Tsujinaka, Hiroya Takiuchi, Hiroshi Furukawa, A phase ll study of Trastuzumab in combination with triweekly S-1 plus CDDP in HER2-positive advanced gastric cancer; OGSG1101, HGCSG1102, T-CORE1101 Intergroup study(HERBIS-1 trial), ASCO-GI 2013.